HHS Study Concludes Gender-Affirming Interventions on Children Cause Irreparable Harm, Including Sterilization, as Most Would Naturally Outgrow Dysphoria
- Elisa Ballard
- 1 day ago
- 5 min read
In November of 2025, a comprehensive, peer-reviewed study was released by the U.S. Department of Health and Human Services (HHS) that delivered a scathing indictment of “gender-affirming care” for minors, concluding that puberty blockers, cross-sex hormones, and surgeries. These interventions expose children and adolescents to significant, often irreversible harms with virtually no reliable evidence of long-term benefit. Commissioned in response to President Trump’s January 2025 Executive Order “Protecting Children from Chemical and Surgical Mutilation,” the 400-plus-page report, titled Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices, finds that these interventions frequently result in sterility, sexual dysfunction, impaired bone development, and other lifelong consequences—while the vast majority of children experiencing gender dysphoria would resolve their distress naturally if allowed to progress through puberty without medical interference.
The report’s authors, drawing on an umbrella review of systematic studies and physiological evidence, emphasize that the evidence base for these treatments is “very low” quality. Systematic reviews show no robust proof that puberty blockers, hormones, or surgeries improve mental health, alleviate gender dysphoria, or reduce suicide risk. Instead, the interventions carry well-documented risks that are inadequately tracked and often downplayed. Among the most devastating are infertility and sterility. Puberty blockers halt natural gamete development; when followed by cross-sex hormones—as occurs in over 90% of cases—the result is frequently permanent sterilization. Fertility preservation options remain experimental and rarely successful in this population. Surgeries, such as mastectomies or genital procedures performed on adolescents whose puberty was artificially blocked, compound the damage with complications including loss of sexual function, scarring, and the irreversible removal of healthy tissue.
“Existing research suggests [gender dysphoria] will remit without intervention in most cases,” the executive summary states bluntly. Historical data confirms this conclusion, particularly when children are not socially or medically transitioned early. One analysis cited in the report found that over 70% of adolescent females diagnosed between ages 15–19 no longer met criteria for gender dysphoria five years later. The report notes that gender dysphoria often fluctuates during adolescence, with no reliable way to predict persistence. Yet the “gender-affirming” model—pushing immediate social transition, blockers as a supposed “pause button,” and rapid progression to hormones—appears to lock in a pathway that prevents natural resolution and may itself contribute to persistence.
The HHS study does not mince words about how this experimental approach became entrenched. It levels sharp criticism at the small circle of medical committees and organizations that drove the narrative despite weak evidence and ignored harms. The World Professional Association for Transgender Health (WPATH) comes under particular scrutiny: its Standards of Care Version 8 suppressed systematic reviews that undermined preferred treatments, violated conflict-of-interest rules, and removed age minimums under political pressure. The Endocrine Society’s guidelines, heavily interdependent with WPATH, similarly lack methodological rigor and prioritize aesthetic “affirmation” over patient safety. The American Academy of Pediatrics (AAP) and other U.S. medical associations helped create a false perception of professional consensus by relying on these flawed documents while sidelining dissent and broader evidence reviews. “This apparent consensus… is driven primarily by a small number of specialized committees, influenced by WPATH,” the report states. These groups minimized comprehensive mental-health assessments, rushed children into irreversible pathways, and cast suspicion on psychotherapy—despite systematic reviews finding no harms from non-invasive psychosocial approaches.
The consequences have been stark. Claims data show nearly 14,000 minors received these procedures between 2019 and 2023 alone. Internationally, countries including the United Kingdom, Sweden, Finland, and others have already reversed course, banning routine use of puberty blockers and restricting hormones and surgeries to tightly controlled research settings after their own evidence reviews reached similar conclusions about weak benefits and disproportionate risks.
Peer reviewers who vetted the HHS report—including experts in evidence-based medicine and pediatric endocrinology—largely endorsed its rigorous methodology and conclusions, affirming the “very low” certainty of benefits, the reality of physiological harms such as infertility, and the ethical imperative to prioritize psychotherapy and address co-occurring mental-health conditions instead of rushing to medicalize distressed youth.
HHS Secretary Robert F. Kennedy Jr. and the report’s authors stress that the priority must now shift to protecting children through evidence-based care: thorough psychosocial evaluation, treatment of underlying issues such as autism, trauma, or same-sex attraction, and allowing natural development. The study calls for better long-term data collection and warns that continuing the current practices violates basic medical ethics when harms are known and benefits unproven.
Prior to (and now reinforced by) the HHS report, officials in various states moved to frame gender-affirming care as child abuse due to the risks of permanent harm. Texas (via Attorney General Ken Paxton's February 2022 opinion KP-0401 and Governor Greg Abbott's directive) was the most prominent early example of directing child protective services (CPS/DFPS) to investigate parents and providers. However, it was not unique:
Florida: In 2023, legislation allowed the state to take custody of a minor present in Florida if the child was receiving (or at risk of receiving) gender-affirming care, effectively treating parental facilitation or provider actions as grounds for intervention akin to abuse/neglect. Governor Ron DeSantis and state officials described such procedures on minors as harmful and not medically necessary.
Missouri: Attorney General Andrew Bailey issued emergency regulations and statements in 2023 restricting youth gender interventions, describing them as potentially deceptive or harmful practices. Some interpretations and debates linked facilitation to child abuse concerns, with calls for investigations into clinics.
Alabama: Early 2022 legislation (and related statements) restricted care and contributed to a broader environment where providing certain interventions was treated as serious misconduct warranting penalties, with some rhetoric equating it to harm against children.
Other mentions: Some bills or proposals in states like Arizona, Oklahoma, and Indiana included language that could classify aiding minors in accessing certain procedures as child abuse or neglect. Indiana and others had "aiding and abetting" provisions tied to bans, with potential CPS implications.
By 2025–2026, 27 states have enacted laws or policies limiting or banning gender-affirming medical interventions for minors. Many have imposed criminal penalties (felonies in states like Alabama, Florida, Idaho, North Dakota, Oklahoma, South Carolina for providers), professional discipline, license revocation, civil liability, or restrictions on public funding/Medicaid coverage. States frequently justify these laws as protecting children from experimental or harmful treatments, using language like “child mutilation” or “irreversible damage.” Examples include Arkansas (first ban in 2021), Tennessee, Kentucky, Ohio, and others. The U.S. Supreme Court’s 2025 ruling in United States v. Skrmetti upheld Tennessee’s ban, affirming states’ authority and removing equal protection barriers for similar laws.
In contrast to this report's findings, California treats gender-affirming care as a protected right and form of medically necessary healthcare, not child abuse. It has built a legal framework to facilitate access (with parental consent for minors) and resist external restrictions. However, practical availability for youth has narrowed in 2025–2026 due to federal funding pressures and provider caution, even as state policy remains strongly supportive.
The HHS report’s executive summary concludes, “Health authorities in a number of countries have imposed restrictions… Having recognized the experimental nature of these medical interventions and their potential for harm (which has been inadequately studied, especially with respect to long-term outcomes).” For thousands of American families and the children already harmed, the findings arrive as a long-overdue reckoning. The question remains: Will states like California finally recognize the harm these medical interventions are causing?
For more details, you can read the report at:
